<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>Chapter 03 Prohibited Acts | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/09.10.03/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/09.10.03/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|09|10|03|"/>
    <meta itemprop="doc-type" content="container" data-document=""/>
    <meta itemprop="doc-num" content="03"/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="09|10|03" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="http://regs.maryland.gov//us/md/exec/comar/09.10.03"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="Chapter 03 Prohibited Acts | Library of Maryland Regulations"/>
    <meta property="og:image" content="http://regs.maryland.gov//us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/09.10.03/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/09.10.03/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|09" data-search-heading="">
                  <a href="/us/md/exec/comar/09" title="Title 09 MARYLAND DEPARTMENT OF LABOR">Title 09 MARYLAND DEPARTMENT OF LABOR</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|09|10" data-search-heading="">
                  <a href="/us/md/exec/comar/09.10" title="Subtitle 10 RACING COMMISSION">Subtitle 10 RACING COMMISSION</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|09|10|03" data-search-heading="">
                  <span title="Chapter 03 Prohibited Acts">Chapter 03 Prohibited Acts</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="09|10|03">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/md/exec/comar/09.10.03">Chapter 03 Prohibited Acts</h1>
                <section class="line-group annotations">
                  <h2>Administrative History</h2>
                  <p>Effective date: January 2, 1994 (20:26 Md. R. 2027)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.01" title=".01 Definitions.">Regulation .01</a> amended as an emergency provision effective May 18, 2017 (44:12 Md. R. 585); emergency status expired September 1, 2017</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.01" title=".01 Definitions.">Regulation .01</a> amended effective September 25, 2017 (44:19 Md. R. 896)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.01#B" title="">Regulation .01B</a> amended as an emergency provision effective October 27, 1995 (22:23 Md. R. 1794); emergency status expired April 1, 1996</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.01#B" title="">Regulation .01B</a> amended effective October 29, 2001 (28:21 Md. R. 1855); October 24, 2005 (32:21 Md. R. 1707)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.01#B" title="">Regulation .01B</a> amended as an emergency provision effective January 1, 2009 (35:24 Md. R. 2068); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.01#B" title="">Regulation .01B</a> amended effective October 15, 2012 (39:20 Md. R. 1306); January 1, 2014 (40:20 Md. R. 1651); December 19, 2016 (43:25 Md. R. 1384)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.01#B" title="">Regulation .01B</a> amended as an emergency provision effective February 1, 2020 (47:4 Md. R. 260); amended permanently effective May 18, 2020 (47:10 Md. R. 515)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.01-1" title=".01-1 Restricted Use of Medications and Other Substances.">Regulation .01-1</a> adopted effective January 1, 2014 (40:20 Md. R. 1651)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.01-1" title=".01-1 Restricted Use of Medications and Other Substances.">Regulation .01-1</a> amended effective October 13, 2014 (41:20 Md. R. 1112)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.01-1" title=".01-1 Restricted Use of Medications and Other Substances.">Regulation .01-1</a> amended as an emergency provision effective May 24, 2016 (43:13 Md. R. 711); amended permanently effective October 24, 2016 (43:21 Md. R 1165)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.01-1" title=".01-1 Restricted Use of Medications and Other Substances.">Regulation .01-1</a> amended as an emergency provision effective February 1, 2020 (47:4 Md. R. 260); amended permanently effective May 18, 2020 (47:10 Md. R. 515)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.01-1" title=".01-1 Restricted Use of Medications and Other Substances.">Regulation .01-1</a> amended as an emergency provision effective November 1, 2021 (48:24 Md. R. 1024); adopted permanently effective February 7, 2022 (49:3 Md. R. 138)</p>
                  <p>Regulation .01-1E-1 adopted as an emergency provision effective August 1, 2015 (42:16 Md. R. 1052); adopted permanently effective October 26, 2015 (42:21 Md. R. 1300)</p>
                  <p>Regulation .01-1E repealed and Regulation 01-1E-1 renumbered to be new Regulation .01-1E effective March 1, 2021 (48:4 Md. R. 176)</p>
                  <p>Regulation .01-1G amended effective March 26, 2018 (45:6 Md. R. 318)</p>
                  <p>Regulation .01-1M-1 adopted effective February 29, 2016 (43:4 Md. R. 331)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.01-2" title=".01-2 Medical Records.">Regulation .01-2</a> adopted effective April 1, 2020 (47:6 Md. R. 341)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.02" title=".02 Sanctions.">Regulation .02</a> amended as an emergency provision effective January 1, 2015 (42:1 Md. R. 12); amended permanently effective February 16, 2015 (42:3 Md. R. 315)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.02#C" title="">Regulation .02C</a> amended effective April 24, 2017 (44:8 Md. R. 401)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.03#A" title="">Regulation .03A</a> amended effective April 28, 2003 (30:8 Md. R. 539)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.03#C" title="">Regulation .03C</a> adopted as an emergency provision effective October 28, 2002 (29:23 Md. R. 1807); adopted permanently effective April 28, 2003 (30:8 Md. R. 539)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.03#C" title="">Regulation .03C</a> amended effective August 15, 2005 (32:16 Md. R. 1392); December 28, 2020 (47:26 Md. R. 1107)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.04" title=".04 Drug Prohibition — Horses.">Regulation .04</a> amended effective October 29, 2001 (28:21 Md. R. 1855); January 1, 2014 (40:20 Md. R. 1651)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.04#A" title="">Regulation .04A</a> amended effective July 4, 1994 (21:13 Md. R. 1155); April 22, 2019 (46:8 Md. R. 401)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.04#C" title="">Regulation .04C</a> amended effective October 6, 1997 (24:20 Md. R. 1403)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.04#D" title="">Regulation .04D</a>-1 adopted effective March 27, 2006 (33:6 Md. R. 578)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.04#G" title="">Regulation .04G</a> amended effective March 27, 2006 (33:6 Md. R. 578)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.05#A" title="">Regulation .05A</a> amended effective March 13, 1995 (22:5 Md. R. 366); October 30, 2000 (27:21 Md. R. 1974)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.05#D" title="">Regulation .05D</a> amended effective January 16, 1995 (22:1 Md. R. 19)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.08" title=".08 Bleeders.">Regulation .08</a> amended effective May 4, 1998 (25:9 Md. R. 678); November 30, 1998 (25:24 Md. R. 1772); October 29, 2001 (28:21 Md. R. 1855); September 30, 2002 (29:19 Md. R. 1523); October 24, 2005 (32:21 Md. R. 1707); January 1, 2014 (40:20 Md. R. 1651)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.08#A" title="">Regulation .08A</a> amended as an emergency provision effective July 31, 2020 (47:18 Md. R. 823); emergency status expired December 28, 2020</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.08#A" title="">Regulation .08A</a> amended effective December 28, 2020 (47:26 Md. R. 1107)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.08#A" title="">Regulation .08A</a>-1 adopted as an emergency provision effective July 31, 2020 (47:18 Md. R. 823); emergency status expired December 28, 2020</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.08#A" title="">Regulation .08A</a>-1 adopted effective December 28, 2020 (47:26 Md. R. 1107)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.08#G" title="">Regulation .08G</a> amended as an emergency provision effective March 15, 2021 (48:7 Md. R. 258); amended permanently effective June 28, 2021 (48:13 Md. R. 508)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.08#H" title="">Regulation .08H</a> amended effective January 16, 1995 (22:1 Md. R. 19)</p>
                  <p>Regulation .08I amended effective October 9, 1995 (22:20 Md. R. 1542)</p>
                  <p>Regulation .08I amended as an emergency provision effective October 27, 1995 (22:23 Md. R. 1794); emergency status expired April 1, 1996</p>
                  <p>Regulation .08I amended as an emergency provision effective April 2, 1996 (23:7 Md. R. 548); amended permanently effective August 26, 1996 (23:17 Md. R. 1247)</p>
                  <p>Regulation .08J amended effective May 5, 1997 (24:9 Md. R. 656)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.09#H" title="">Regulation .09H</a> amended effective August 14, 1995 (22:16 Md. R. 1220)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.10" title=".10 Out-of-Competition Testing.">Regulation .10</a> adopted as an emergency provision effective May 18, 2017 (44:12 Md. R. 585); emergency status expired September 1, 2017</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.03.10" title=".10 Out-of-Competition Testing.">Regulation .10</a> adopted effective September 25, 2017 (44:19 Md. R. 896)</p>
                  <h2>Authority</h2>
                  <p><a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gbr&amp;section=11-210" title="">Business Regulation Article, §11-210, </a>Annotated Code of Maryland</p>
                </section>
                <h2 id="/us/md/exec/comar/09.10.03.01" data-order="|09|10|03|.01|" data-ref-path="09|10|03|.01" class="h__section">.01 Definitions.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01#A">A.</span> The definitions set forth in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gbr&amp;section=11-210" title="">Business Regulation Article, §11-210, Annotated Code of Maryland</a>, apply in this chapter, unless otherwise noted.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01#B">B.</span> In addition, the following terms have the meanings indicated.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01#B(1)">(1)</span> “ARCI” means the Association of Racing Commissioners International, Inc., a trade organization of the official governing rule making bodies for horse racing in North America with pari-mutuel betting.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01#B(2)">(2)</span> “Drug” means a substance which may have a pharmacological effect on a horse, and:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01#B(2)(a)">(a)</span> Which does not exist naturally in the untreated horse at a normal physiological concentration;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01#B(2)(b)">(b)</span> Is defined as a controlled dangerous substance under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-101" title="">Criminal Law Article, §5-101, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01#B(2)(c)">(c)</span> Is intended to be used for the diagnosis, cure, mitigation, treatment, or prevention of diseases affecting a human or other animal;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01#B(2)(d)">(d)</span> Other than food, is intended to affect the structure or a function of the body of a human or other animal;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01#B(2)(e)">(e)</span> Is intended for use as a component of an item specified in §B(2)(a)—(d) of this regulation; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01#B(2)(f)">(f)</span> Includes the detection of two or more non-steroidal anti-inflammatory drugs in blood plasma or urine or both.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01#B(3)">(3)</span> “Judges” means those individuals appointed by the Commission to enforce the regulations of the Commission at a harness race track.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01#B(4)">(4)</span> “State” means the State of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01#B(5)">(5)</span> “Stewards” means those individuals appointed by the Commission to enforce the regulations of the Commission at a thoroughbred race track.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/09.10.03.01-1" data-order="|09|10|03|.01-1|" data-ref-path="09|10|03|.01-1" class="h__section">.01-1 Restricted Use of Medications and Other Substances.</h2>
                <p>The use of the following medications and other substances is permitted if quantitated at not more than the specified thresholds:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#A">A.</span> Acepromazine quantitated at not more than 10 nanograms per milliliter of HEPS in urine;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#B">B.</span> Albuterol quantitated at not more than 1 nanogram per milliliter of urine;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#C">C.</span> Butorphanol quantitated at not more than 300 nanograms per milliliter of total butorphanol in urine, or 2 nanograms per milliliter of free butorphanol in blood plasma or serum;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#D">D.</span> Caffeine quantitated at not more than 100 nanograms per milliliter of blood plasma or serum;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#E">E.</span> Cetirizine quantitated at not more than 6 nanograms per milliliter of blood plasma or serum;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#F">F.</span> Cimetidine quantitated at not more than 400 nanograms per milliliter of blood plasma or serum;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#G">G.</span> Cobalt quantitated at not more than 25 nanograms per milliliter of blood plasma or serum;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#H">H.</span> Dantrolene qunatitated at not more than 100 picrograms per milliliter of 5-hydroxydantrolene in blood plasma or serum;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#I">I.</span> Detomidine quantitated at not more than 2 nanograms per milliliter of carboxydetomidine in urine, or 1 nanogram of detomidine per milliliter of blood plasma or serum;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#J">J.</span> Dimethlysulfoxide (DMSO) quantitated at not more than 10 micrograms per milliliter of blood plasma or serum;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#K">K.</span> Flunixin quantitated at not more than 5 nanograms per milliliter of blood plasma or serum;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#L">L.</span> Furosemide (Lasix), as provided in <a class="internal-link " href="/us/md/exec/comar/09.10.03.08" title=".08 Bleeders.">Regulation .08 of this chapter</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#M">M.</span> Gamma aminobutyric acid quantitated at not more than 110 nanograms per milliliter of blood plasma or serum;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#N">N.</span> Glycopyrrolate quantitated at not more than 3 picograms per milliliter of blood plasma or serum;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#O">O.</span> Guaifenesin quantitated at not more than 12 nanograms per milliliter of blood plasma or serum;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#P">P.</span> Ketoprofen quantitated at not more than 2 nanograms per milliliter of blood plasma or serum;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#Q">Q.</span> Lidocaine quantitated at not more than 20 picograms per milliliter of total 3-hydroxylidocaine in blood plasma or serum;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#R">R.</span> Mepivacaine quantitated at not more than 10 nanograms per milliliter of total hydroxymepivacaine in urine, or the limit of detection of mepivacaine in blood plasma or serum;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#S">S.</span> Methocarbamol quantitated at not more than 1 nanogram per milliliter of blood plasma or serum;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#T">T.</span> Methylprednisolone quantitated at not more than 100 picograms per milliliter of blood plasma or serum;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#U">U.</span> Omeprazole quantitated at not more than 10 nanograms per milliliter of blood plasma or serum;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#V">V.</span> Phenylbutazone quantitated at not more than 0.3 micrograms per milliliter of the blood plasma or serum;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#W">W.</span> Procaine Penicillin quantitated at not more than 25 nanograms per milliliter of blood plasma or serum;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#X">X.</span> Ranitidine quantitated at not more than 40 nanograms per milliliter of blood plasma or serum;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#Y">Y.</span> Xylazine quantitated at not more than 200 picigrams per milliliter of blood plasma or serum;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#Z">Z.</span> Nandrolone quantitated at not more than 1 nanogram per milliliter of urine taken from a gelding, filly, or mare;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#AA">AA.</span> Boldenone quantitated at not more than 15 nanograms per milliliter of urine taken from a colt or horse;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#BB">BB.</span> Testosterone quantitated at not more than 20 nanograms per milliliter of urine taken from a gelding; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.01-1#CC">CC.</span> Testosterone quantitated at not more than 55 nanograms per milliliter of urine taken from a filly or mare.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/09.10.03.01-2" data-order="|09|10|03|.01-2|" data-ref-path="09|10|03|.01-2" class="h__section">.01-2 Medical Records.</h2>
                <p>The health and medical record of a horse shall include the name of the horse and all medications, drugs, substances, or procedures administered by an individual or prescribed or administered by a veterinarian for up to the previous 3 years.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/09.10.03.02" data-order="|09|10|03|.02|" data-ref-path="09|10|03|.02" class="h__section">.02 Sanctions.</h2>
                <p>In addition to a specific sanction applicable to a particular violation, an individual found by the:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.02#A">A.</span> Stewards or judges to have violated a provision of this chapter may be subject to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.02#A(1)">(1)</span> A fine of up to $2,500;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.02#A(2)">(2)</span> The suspension of any license issued by the Commission for a period of up to 360 days; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.02#A(3)">(3)</span> Referral to the Commission for additional sanctions if the stewards or judges determine that a greater sanction is warranted than they are empowered to impose; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.02#B">B.</span> Commission to have violated a provision of this chapter may be subject to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.02#B(1)">(1)</span> A fine of up to $5,000;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.02#B(2)">(2)</span> The suspension or revocation of any license issued by the Commission; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.02#B(3)">(3)</span> Certain conditions of licensure as imposed by the Commission.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.02#C">C.</span> Multiple Medication Violations.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.02#C(1)">(1)</span> A trainer who receives a penalty for a medication violation based upon a horse testing positive for a Class 1—5 medication with Penalty Class A—C, as provided in the most recent version of the Association of Racing Commissioners International Uniform Classification Guidelines for Foreign Substances, shall be assigned points as follows:</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th>Penalty Class</th>
                        <th>Points for <br/>Controlled Medication</th>
                        <th>Points for <br/>Noncontrolled Medication</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">Class A</td>
                        <td data-text-align="center" data-vertical-align="middle">N/A</td>
                        <td data-text-align="center" data-vertical-align="middle">6</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Class B</td>
                        <td data-text-align="center" data-vertical-align="middle">2</td>
                        <td data-text-align="center" data-vertical-align="middle">4</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Class C</td>
                        <td data-text-align="center" data-vertical-align="middle">1/2, with incremental increases of 1/2 point for each additional violation within 365 days</td>
                        <td data-text-align="center" data-vertical-align="middle">1, with incremental increases of 1/2 point for each additional violation within 365 days</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Class D</td>
                        <td data-text-align="center" data-vertical-align="middle">0</td>
                        <td data-text-align="center" data-vertical-align="middle">0</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.02#C(2)">(2)</span> The points assigned to a medication violation by the stewards or judges shall not be applied until a final adjudication of the enforcement of any such violation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.02#C(3)">(3)</span> A trainer’s cumulative points for violations in all racing jurisdictions shall be maintained by the Association of Racing Commissioners International. Once all appeals are waived or exhausted, the points shall immediately become part of the trainer’s official record and shall be considered by the Commission in its determination to subject the trainer to the mandatory enhanced penalties by the stewards or judges as provided in this regulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.02#C(4)">(4)</span> If the Stewards, Judges, or Commission determine that the violation is due to environmental contamination, they may assign fewer or no points against the trainer based upon the specific facts of the case.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.02#C(5)">(5)</span> Multiple positive tests for the same medication incurred by a trainer prior to delivery of the official notice by the laboratory may be treated as a single violation. In the case of a positive test indicating multiple substances found in a single post-race sample, the stewards or judges may treat each substance found as an individual violation for which points will be assigned.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.02#C(6)">(6)</span> The stewards or judges shall consider all points for violations in all racing jurisdictions as contained in the trainer’s official record when determining whether the mandatory enhancements provided in this regulation shall be imposed.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.02#C(7)">(7)</span> In addition to the penalty for the underlying offense, the following penalty shall be imposed upon a licensed trainer based upon the cumulative points contained in their official record:</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th>Points</th>
                        <th>Suspension in Days</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">5—5.5</td>
                        <td data-vertical-align="middle">15 to 30</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">6—8.5</td>
                        <td data-vertical-align="middle">30 to 60</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">9—10.5</td>
                        <td data-vertical-align="middle">90 to 180</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">11 or more</td>
                        <td data-vertical-align="middle">180 to 360</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.02#C(8)">(8)</span> Multiple medication points are not a substitute for the current penalty system and are intended to be an additional uniform penalty when the licensee:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.02#C(8)(a)">(a)</span> Has more than one violation for the relevant time period; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.02#C(8)(b)">(b)</span> Exceeds the permissible number of points.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.02#C(9)">(9)</span> The suspension periods, as provided in <a class="internal-link " href="/us/md/exec/comar/09.10.03.02#C(6)" title="">§C(6) of this regulation</a>, shall run consecutive to any suspension imposed for the underlying offense.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.02#C(10)">(10)</span> The stewards’ or judges’ ruling shall distinguish between the penalty for the underlying offense and any penalty based upon a steward’s or judge’s review of a the trainer’s cumulative points and regulatory record, which may be considered an aggravating factor in a case.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.02#C(11)">(11)</span> Points assigned to a trainer for a medication violation shall expire on the anniversary date of the date the suspension is completed as follows:</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th>Penalty Classification</th>
                        <th>Time to Expungement</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">A</td>
                        <td data-vertical-align="middle">3 years</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">B</td>
                        <td data-vertical-align="middle">2 years</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">C</td>
                        <td data-vertical-align="middle">1 year</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/09.10.03.03" data-order="|09|10|03|.03|" data-ref-path="09|10|03|.03" class="h__section">.03 General.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A">A.</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/09.10.03.03#A(14)" title="">§A(14) of this regulation</a>, the following acts are prohibited if committed on the grounds of a facility under the jurisdiction of the Commission, if they affect a race conducted live in this State, or if they affect the betting on a race in this State:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A(1)">(1)</span> Offering, promising, giving, accepting, or soliciting a bribe in any form, directly or indirectly, to or by a person having any connection with the outcome of a race;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A(2)">(2)</span> Entering, or knowingly aiding and abetting in the entering of, a horse ineligible or unqualified to race;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A(3)">(3)</span> Participating in any improper, corrupt, or fraudulent act or practice in relation to racing;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A(4)">(4)</span> Causing, attempting to cause, or any participation in an attempt to cause the pre-arrangement of a race result;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A(5)">(5)</span> Soliciting bets on a horse from the public by a licensee either by correspondence or other methods;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A(6)">(6)</span> Using or possessing a battery, buzzer, electrical device, or other appliance, other than an ordinary whip, which could be used to alter the speed or racing condition of a horse in a race or workout;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A(7)">(7)</span> Using profane, abusive, or insulting language to employees of the Commission, employees of a facility under the jurisdiction of the Racing Commission, or the public;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A(8)">(8)</span> Being in an intoxicated state;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A(9)">(9)</span> Fighting or other conduct of a disorderly nature;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A(10)">(10)</span> Using or possessing a deadly weapon;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A(11)">(11)</span> Committing or participating in the commission of a criminal act;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A(12)">(12)</span> Violating a regulation or condition of the Commission or aiding or abetting a person in the violation of a regulation or condition of the Commission;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A(13)">(13)</span> Failing to comply with an order or ruling of a steward, judge, or other racing official pertaining to a racing matter;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A(14)">(14)</span> Cruelty to a horse wherever committed;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A(15)">(15)</span> Tampering, or attempting to tamper, with a horse for any purpose;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A(16)">(16)</span> Transferring, or attempting to transfer, the ownership of a horse for a purpose other than its legitimate sale or lease;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A(17)">(17)</span> Registering a horse under the name of a person other than the legitimate owner or lessee of the horse;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A(18)">(18)</span> Making false or misleading statements to a racing official or submitting false or misleading statements on a license application;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A(19)">(19)</span> Except as otherwise provided in this regulation, using or possessing, actually or constructively, any of the following items:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A(19)(a)">(a)</span> A drug, or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A(19)(b)">(b)</span> A hypodermic needle, hypodermic syringe, or other device which could be used for injection;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A(20)">(20)</span> Using or possessing the ingredients or the paraphernalia associated with the forced feeding to a horse of a combination of baking soda and sugar, or a form of sugar, or administrating a substance by tubing within 24 hours of a racing program in which a horse is scheduled to race;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A(21)">(21)</span> The possession or administration of Erythropoietin or any analogous substance that increases the oxygen-carrying capacity of the blood; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#A(22)">(22)</span> Failing to report the knowledge of a violation of this regulation to the stewards, judges, or the Commission.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#B">B.</span> The use or possession of the items listed in §A(19)(a) and (b) of this regulation is permissible if the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#B(1)">(1)</span> Item is possessed or used for a legitimate purpose by a licensed veterinarian;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#B(2)">(2)</span> Item is possessed or used pursuant to a valid prescription or order from a medical practitioner while acting in the course of the practitioner's professional practice; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#B(3)">(3)</span> Stewards or judges, in their discretion, grant permission authorizing the possession or use of the item.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#C">C.</span> The use of a shockwave therapy device is prohibited unless:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#C(1)">(1)</span> The device is registered with the Commission Veterinarian;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#C(2)">(2)</span> The device is used by a licensed veterinarian;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#C(3)">(3)</span> The device is used on a horse at least 10 days before the horse participates in a race or workout; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.03#C(4)">(4)</span> Each use of the device is reported to the stewards on a daily medication report as provided in <a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.01.47#K" title="">COMAR 09.10.01.47K</a> and <a class="internal-link no-wrap" href="/us/md/exec/comar/09.10.02.39#F(3)" title="">COMAR 09.10.02.39F(3)</a> and (4).</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/09.10.03.04" data-order="|09|10|03|.04|" data-ref-path="09|10|03|.04" class="h__section">.04 Drug Prohibition — Horses.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.04#A">A.</span> Other than Lasix administered in accordance with the regulations in this chapter, an individual may not administer, cause to be administered, participate, or attempt to participate in any way in the administration of any drug or medication to a horse:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.04#A(1)">(1)</span> During the 24-hour period before the scheduled post time for the race in which the horse is to participate; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.04#A(2)">(2)</span> Until after the race in which the horse is programmed to participate is run.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.04#B">B.</span> A horse participating in a race may not carry in its body:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.04#B(1)">(1)</span> A drug; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.04#B(2)">(2)</span> A medication or other substance quantitated at more than the thresholds prescribed in <a class="internal-link " href="/us/md/exec/comar/09.10.03.01-1" title=".01-1 Restricted Use of Medications and Other Substances.">Regulation .01-1 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.04#C">C.</span> The presence of a drug or a medication or other substance quantitated at more than the thresholds prescribed in <a class="internal-link " href="/us/md/exec/comar/09.10.03.01-1" title=".01-1 Restricted Use of Medications and Other Substances.">Regulation .01-1 of this chapter</a> in the post-race urine, blood, or other sample taken from a horse is prima facie evidence that the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.04#C(1)">(1)</span> Horse was administered a drug and carried the drug in its body during the race; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.04#C(2)">(2)</span> Drug was administered by the person or persons having control, care, or custody of the horse.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.04#D">D.</span> The presence of a drug, as defined in Regulation .01B(1)(a)(i) of this chapter, in a prerace blood sample taken from a horse that participated in a race, is prima facie evidence that the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.04#D(1)">(1)</span> Horse was administered a drug and carried the drug in its body during the running of the race; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.04#D(2)">(2)</span> Drug was administered by the person or persons having control, care, or custody of the horse.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.04#E">E.</span> Trainer Responsibility. A trainer is the absolute insurer of, and responsible for, the condition of each horse the trainer enters in a race, regardless of the acts of third parties.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.04#F">F.</span> Enforcement.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.04#F(1)">(1)</span> The stewards or judges may order the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.04#F(1)(a)">(a)</span> Post-race taking of urine, blood, or other samples for testing purposes from any horse which participated in a race;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.04#F(1)(b)">(b)</span> Prerace taking of blood samples for testing purposes from any horse entered in a race to determine the presence of a drug, as defined in Regulation .01B(1)(a)(i) of this chapter;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.04#F(1)(c)">(c)</span> Denial, forfeiture, and prompt return of a purse, sweepstakes, trophy, or any other reward received by the owner of a horse found to have carried a drug or a medication or other substance quantitated at more than the thresholds prescribed in <a class="internal-link " href="/us/md/exec/comar/09.10.03.01-1" title=".01-1 Restricted Use of Medications and Other Substances.">Regulation .01-1 of this chapter</a> in its body during a race;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.04#F(1)(d)">(d)</span> Redistribution of the items denied, forfeited, and returned, resulting from the disqualification of a horse found to have carried a drug or a medication or other substance quantitated at more than the thresholds prescribed in <a class="internal-link " href="/us/md/exec/comar/09.10.03.01-1" title=".01-1 Restricted Use of Medications and Other Substances.">Regulation .01-1 of this chapter</a> in its body during a race, to those owners whose horses were advanced by the disqualification.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.04#F(2)">(2)</span> If the stewards or judges order a disqualification due to a horse having carried a drug or a medication or other substance quantitated at more than the thresholds prescribed in <a class="internal-link " href="/us/md/exec/comar/09.10.03.01-1" title=".01-1 Restricted Use of Medications and Other Substances.">Regulation .01-1 of this chapter</a> in its body during a race, they shall issue a ruling announcing the disqualification.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.04#G">G.</span> Repeat Violations. An individual guilty of violating this regulation, or a comparable regulation of another racing jurisdiction, for the second time is considered a repeat offender, and the stewards, judges, or the Commission shall weigh this factor in determining a sanction.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/09.10.03.05" data-order="|09|10|03|.05|" data-ref-path="09|10|03|.05" class="h__section">.05 Drug Prohibition — Humans.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#A">A.</span> Drug Testing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#A(1)">(1)</span> The stewards or judges may direct a licensee to deliver a specimen of urine, or submit to another noninvasive test, in the presence of the track physician or other representative appointed by the Commission, for the detection of an impermissible drug, using as a basis for this directive:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#A(1)(a)">(a)</span> Reasonable cause for any licensee; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#A(1)(b)">(b)</span> Random selection for a licensee who:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#A(1)(b)(i)">(i)</span> As part of the licensee's duties and responsibilities, comes into contact with a horse; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#A(1)(b)(ii)">(ii)</span> Is employed by the association as a part of the security force in the backstretch area of the racetrack.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#A(2)">(2)</span> Random drug testing, as provided by <a class="internal-link " href="/us/md/exec/comar/09.10.03.05#A(1)(b)" title="">§A(1)(b) of this regulation</a>, may be accomplished by the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#A(2)(a)">(a)</span> Testing of all licensees in a category of licensure;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#A(2)(b)">(b)</span> Selection by lottery of licensees within a category of licensure; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#A(2)(c)">(c)</span> Selection of licensees who have a documented, or otherwise verified, history of prior drug use within the previous 5 years.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#A(3)">(3)</span> For the purposes of <a class="internal-link " href="/us/md/exec/comar/09.10.03.05#A(2)(c)" title="">§A(2)(c) of this regulation</a>, the stewards or judges may not direct a licensee to submit to a drug test more than once in a calendar week.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#B">B.</span> A sufficient quantity of the specimen shall be collected to provide for a split sample when possible.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#C">C.</span> Refusal to submit a specimen as directed by the stewards, judges, or designated Commission representative without good cause shall subject an individual to disciplinary action as provided in this chapter, and the individual may not be permitted to continue to function in the individual's licensed capacity pending a hearing on the matter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#D">D.</span> The presence of a drug or the metabolite of a drug in a specimen is considered a positive specimen, unless it is determined by the stewards, judges, or the Commission that the presence of a drug or the metabolite of a drug in a specimen was not due to purposeful use by the licensee.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#E">E.</span> An individual whose specimen is positive is subject to an evaluation and disciplinary action as provided in this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#F">F.</span> Disciplinary Action and Evaluation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#F(1)">(1)</span> For an individual's initial violation under this regulation, the individual shall be suspended until such time as the individual has been professionally evaluated.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#F(2)">(2)</span> If the professional evaluation indicates that the individual's condition is nonaddictive and not detrimental to the best interests of racing, the suspension shall be lifted after the individual:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#F(2)(a)">(a)</span> Provides the results of a drug test which indicates that the individual presently is drug free; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#F(2)(b)">(b)</span> Agrees to submit to drug testing at the direction of the stewards, judges, or designated Commission representative to ensure a continuing drug-free condition.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#F(3)">(3)</span> If the professional evaluation indicates that the individual's condition is addictive or detrimental to the best interests of racing, the suspension remains in effect until such time as the individual:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#F(3)(a)">(a)</span> Provides documented proof of successfully completing a certified drug rehabilitation program approved by the Commission;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#F(3)(b)">(b)</span> Provides the results of a drug test which indicates that the individual presently is drug free; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#F(3)(c)">(c)</span> Agrees to submit to drug testing at the direction of the stewards, judges, or designated Commission representative to ensure a continuing drug-free condition.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.05#G">G.</span> For an individual's second violation under this regulation, the individual shall be suspended for an indefinite period and may apply for reinstatement only in the discretion of the Commission following completion of a certified drug rehabilitation program approved by the Commission.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/09.10.03.06" data-order="|09|10|03|.06|" data-ref-path="09|10|03|.06" class="h__section">.06 Alcohol Detection Test.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.06#A">A.</span> The stewards, judges, or a designated Commission representative may direct a licensee to submit to a noninvasive alcohol detection test for the detection of an impermissible level of alcohol, using as a basis for this order:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.06#A(1)">(1)</span> Reasonable cause for any licensee; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.06#A(2)">(2)</span> Random selection for a licensee who, as part of the licensee's duties and responsibilities, comes into contact with a horse.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.06#B">B.</span> A test which shows a reading of more than 0.05 percent alcohol in the blood subjects the licensee to disciplinary action, and the licensee is not permitted to continue to perform in a licensed capacity on that racing day.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.06#C">C.</span> A licensee who refuses to take an alcohol detection test as directed by the stewards, judges, or designated Commission representative is subject to disciplinary action, and the licensee is not permitted to continue to perform in a licensed capacity on that racing day.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/09.10.03.07" data-order="|09|10|03|.07|" data-ref-path="09|10|03|.07" class="h__section">.07 Search and Seizure.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.07#A">A.</span> The stewards, judges, or designated Commission representatives have the right to enter into or upon the buildings, stables, rooms, automobiles, or any other place within the grounds of a facility under the jurisdiction of the Commission for the purpose of examining them, as well as the personal property and effects of a licensee contained there for the purpose of searching for, and the seizure of, items that constitute evidence of a violation of this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.07#B">B.</span> An individual who has been granted a license by the Commission, by accepting the license, consents to a search and seizure as provided in <a class="internal-link " href="/us/md/exec/comar/09.10.03.07#A" title="">§A of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.07#C">C.</span> A licensee who refuses to permit a search may be disciplined.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/09.10.03.08" data-order="|09|10|03|.08|" data-ref-path="09|10|03|.08" class="h__section">.08 Bleeders.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#A">A.</span> The administration of Lasix to a horse is permissible, except as set forth in §A-1 of this regulation, if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#A(1)">(1)</span> The administration of Lasix is recommended by a practicing veterinarian;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#A(2)">(2)</span> The recommendation is submitted to the State Veterinarian in writing; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#A(3)">(3)</span> The trainer declares the use of Lasix at the time of entry.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#A-1">A-1.</span> No 2-year-old thoroughbred horse or any thoroughbred horse scheduled to compete in a graded stakes race may be administered Lasix (furosemide) within 48 hours of the post time at which it is scheduled to run.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#B">B.</span> A Commission veterinarian is responsible for maintaining up-to-date records of horses which are permitted to use Lasix, and these records shall be available for inspection during the hours of operation of a race track.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#C">C.</span> If a horse has been observed by a Commission veterinarian to have bled from at least one nostril during the running of a race or workout, either on the racing strip or in the barn area, that horse may not be permitted to race for a period of 14 days.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#D">D.</span> If a horse has been observed to have bled as described under <a class="internal-link " href="/us/md/exec/comar/09.10.03.08#C" title="">§C of this regulation</a> within 365 days of the first occurrence, that horse:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#D(1)">(1)</span> May not race for 30 days after the first reoccurrence;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#D(2)">(2)</span> May not race for 180 days after the second reoccurrence; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#D(3)">(3)</span> Is banned from racing forever after the third reoccurrence.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#E">E.</span> For the purpose of counting the number of days a horse is not permitted to race in this State under this section, the day the horse bled is the first day, and the horse shall be permitted to race in this State when the last day has expired.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#F">F.</span> Race Day Administration of Lasix.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#F(1)">(1)</span> Unless a horse has been declared off of Lasix pursuant to <a class="internal-link " href="/us/md/exec/comar/09.10.03.08#G" title="">§G of this regulation</a>, a horse that is permitted to use Lasix shall be administered Lasix on the day of the race only by a veterinarian designated by the Commission to perform such a function.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#F(2)">(2)</span> As indicated by post-race quantitation, a horse may not carry in its body at the time of the running of a race not more than 100 nanograms of Lasix per milliliter of plasma or serum.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#F(3)">(3)</span> Reports.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#F(3)(a)">(a)</span> The veterinarian who administers Lasix to a horse scheduled to race shall prepare a written certification indicating that Lasix was administered.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#F(3)(b)">(b)</span> The written certification shall be in the possession of a designated Commission representative at least 1 hour before the horse is scheduled to race.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#F(3)(c)">(c)</span> The stewards or judges shall order a horse scratched if the written certification is not received in a timely manner.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#G">G.</span> Racing Off of Lasix.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#G(1)">(1)</span> Except for a horse that races in any jurisdiction where the rules of the regulatory authority or the conditions of the race established by the racing association do not permit the use of Lasix, a horse on the Lasix Program that races without Lasix in any jurisdiction which permits the use of Lasix may not be eligible for its use for a period of 60 days.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#G(2)">(2)</span> To become eligible after 60 days, the horse shall have been observed to have bled by a Commission veterinarian either:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#G(2)(a)">(a)</span> Externally; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#G(2)(b)">(b)</span> By endoscopic examination.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#H">H.</span> Program Notice.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#H(1)">(1)</span> Of the horses scheduled to race, the official program shall denote the horses which have been administered:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#H(1)(a)">(a)</span> Lasix; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#H(1)(b)">(b)</span> Lasix for the first time.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.08#H(2)">(2)</span> If the official program contains past performance lines, each past performance line shall indicate if the horse was administered.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/09.10.03.09" data-order="|09|10|03|.09|" data-ref-path="09|10|03|.09" class="h__section">.09 Equine Specimen Testing.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.09#A">A.</span> The stewards or judges may designate a horse entered in a race to give a blood or urine sample, or both, before or following the race.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.09#B">B.</span> At the conclusion of each race, urine and blood samples shall be collected from the winner of the race and any other horses that the Commission or stewards or judges may direct.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.09#C">C.</span> The collection of the urine sample shall be performed by a Commission representative in the presence of the owner, trainer, or designated representative of the horse being tested.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.09#D">D.</span> A State veterinarian, in the presence of the owner, trainer, or designated representative and the Commission representative, shall verify the horse's identifying tattoo number before taking a blood sample from the horse.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.09#E">E.</span> Failure to allow or cooperate in the taking of a sample, or any act or threat to impede, prevent, or otherwise interfere with the taking of a sample, constitutes a violation and subjects the licensee to sanctions as provided in this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.09#F">F.</span> Urine.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.09#F(1)">(1)</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/09.10.03.09#F(2)" title="">§F(2) of this regulation</a>, after the Commission representative obtains the urine specimen from the horse, the Commission representative or the detention barn foreman shall split the specimen into two parts in the presence of the owner, trainer, or designated representative. One portion shall be delivered to the Commission laboratory for testing. The remaining portion shall be maintained in the detention barn until the stewards or judges direct its disposal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.09#F(2)">(2)</span> If the quantity of the urine specimen collected is insufficient to allow for proper testing, the specimen may not be split.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.09#G">G.</span> Blood.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.09#G(1)">(1)</span> After the horse has been washed down, but not less than 30 minutes following the running of the race, a State veterinarian shall extract two tubes of blood from the horse.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.09#G(2)">(2)</span> Of the two tubes of blood drawn under <a class="internal-link " href="/us/md/exec/comar/09.10.03.09#G(1)" title="">§G(1) of this regulation</a>, one shall be forwarded to the Commission laboratory for testing. The remaining tube of blood shall be maintained at the detention barn until the stewards or judges direct its disposal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.09#G(3)">(3)</span> If necessitated by an insufficient quantity of urine having been obtained, another tube of blood shall be drawn and forwarded to the laboratory.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.09#H">H.</span> Split Samples.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.09#H(1)">(1)</span> The Commission, together with the applicable association representing a majority of the owners and trainers racing in Maryland, shall designate laboratories to which split samples of urine and blood may be sent for confirmatory testing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.09#H(2)">(2)</span> Within 72 hours of being notified of a determination by the Commission laboratory that the testing of the blood or urine sample evidences the presence of a drug, the owner or trainer of the horse in question may request that the split sample of urine or blood, or both, be forwarded to one of the designated laboratories for confirmatory testing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.09#H(3)">(3)</span> Upon a request for confirmatory testing, before the split sample is forwarded to the designated laboratory, the owner or trainer and a representative of the Commission shall execute an agreement that binds the owner or trainer and the Commission to the designated laboratory's findings. If the owner or trainer declines to execute the agreement, the split sample may not be forwarded to the designated laboratory for confirmatory testing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.09#H(4)">(4)</span> After testing the split sample, if the designated laboratory:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.09#H(4)(a)">(a)</span> Does not confirm substantially the Commission laboratory's findings, then any allegations that the drug in question was in the horse's system at the time of the race shall be dismissed; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.09#H(4)(b)">(b)</span> Confirms substantially the Commission laboratory's findings, then the finding shall be considered conclusive.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.09#H(5)">(5)</span> If, for whatever reason, confirmatory testing is not possible, §H(1)—(4) of this regulation is of no effect.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.09#I">I.</span> The owner or trainer requesting the confirmatory testing shall bear the costs of the confirmatory testing.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/09.10.03.10" data-order="|09|10|03|.10|" data-ref-path="09|10|03|.10" class="h__section">.10 Out-of-Competition Testing.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#A">A.</span> The Commission may, at a reasonable time on any date, take blood, urine, or other biologic samples from a horse to ensure compliance with applicable medication and anti-doping standards set forth by the Association of Racing Commissioners International, Inc., as such standards may be amended and updated from time to time. The Commission shall own such samples. This regulation authorizes only the collection and testing of samples and does not independently make impermissible the administration to or presence in any horse of any drug or other substance. A race day prohibition or restriction of a substance by the Commission’s regulations is not applicable to an out-of-competition test, unless there is an attempt to race the horse in a manner that violates such regulations.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#B">B.</span> Horses Eligible for Testing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#B(1)">(1)</span> Any horse that has been engaging in activities related to competing in horse racing in the State may be tested. This includes, without limitation, any horses that are training outside the State to participate in racing in the State, and all horses that are training in the State, but excludes weanlings, yearlings, and horses no longer engaged in horse racing (e.g., retired broodmares).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#B(2)">(2)</span> A horse is presumed eligible for out-of-competition testing if:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#B(2)(a)">(a)</span> It is on the grounds at a racetrack or training center under the jurisdiction of the Commission;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#B(2)(b)">(b)</span> It is under the care or control of a trainer licensed by the Commission;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#B(2)(c)">(c)</span> It is owned by an owner licensed by the Commission;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#B(2)(d)">(d)</span> It is entered or nominated to race at a premises licensed by the Commission;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#B(2)(e)">(e)</span> It has raced within the previous 12 months at a premises licensed by the Commission;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#B(2)(f)">(f)</span> It is nominated to a program based on racing in the State.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#B(3)">(3)</span> The presumptions set forth in this regulation are conclusive in the absence of evidence that a horse is not engaged in activities related to competing in horse racing in the State.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#C">C.</span> Selection of Horses to Be Tested.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#C(1)">(1)</span> Horses shall be selected for sampling by a Commission veterinarian, the Executive Director, an equine medical director, a steward, a presiding judge, or a designee of any of the foregoing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#C(2)">(2)</span> Horses may be selected to be tested at random, for cause, or as otherwise determined in the discretion of the Commission.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#C(3)">(3)</span> Licensees of the Commission shall cooperate and comply fully with the provisions of this regulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#C(4)">(4)</span> Individuals who apply for and are granted a trainer or owner license shall be deemed to have given their consent for access at such premises as their horse may be found for the purpose of Commission representatives collecting out-of-competition samples. Licensees shall take any steps necessary to authorize access by Commission representatives at such premises.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#D">D.</span> Collection of Samples.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#D(1)">(1)</span> Samples shall be taken under the supervision and direction of a person who is employed or designated by the Commission. All blood samples shall be collected by a veterinarian licensed in the State, or by a veterinary technician who is acting under appropriate supervision of the State-licensed veterinarian.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#D(2)">(2)</span> Upon request of a representative of the Commission, the trainer, owner, or their specified designee shall provide the location of their horses eligible for out-of-competition testing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#D(3)">(3)</span> The Commission or its designees are not required to provide advance notice before arriving at any location, whether or not licensed by the Commission, to collect samples.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#D(4)">(4)</span> The trainer, owner, or their specified designee shall fully cooperate with the person who takes samples for the Commission, including, but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#D(4)(a)">(a)</span> Assisting in the immediate location and identification of the horse;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#D(4)(b)">(b)</span> Making the horse available as soon as practical upon arrival of the person who is responsible for collecting the samples;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#D(4)(c)">(c)</span> Providing a stall or other safe location to collect the samples;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#D(4)(d)">(d)</span> Assisting the person who is collecting samples in properly procuring the samples; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#D(4)(e)">(e)</span> Witnessing the taking of samples including sealing of sample collection containers.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#D(5)">(5)</span> The management and employees of a licensed racetrack or training facility at which a horse may be located shall cooperate fully with a person who is authorized to take samples. The person who collects samples for the Commission may require that the collection be done at a specified location on such premises.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#D(6)">(6)</span> The Commission, if requested and in its sole discretion, may permit the trainer, owner, or their specified designee to present a horse that is located in the jurisdiction, but not at a racetrack or training center licensed by the Commission, to be sampled at a time and location designated by the Commission.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#E">E.</span> The Commission may arrange for the sampling of an out-of-State horse by the Commission or the Commission’s designee if the horse is located in the State. The Commission or its designee shall follow the relevant provisions of this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#F">F.</span> The test results shall be made available to the Commission, subject to any restrictions on public disclosure of test results that may apply to the Commission.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#G">G.</span> The Commission, if requested and in its sole discretion, may permit the trainer or owner instead to transport the horse into the State for sampling at a time and place designated by the Commission.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#H">H.</span> The individual who takes samples for the Commission shall provide identification and disclose the purpose of the sampling to the trainer or designated attendant of the horse.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#I">I.</span> An owner or trainer does not consent to a search of the premises by making a horse that is not located at a racetrack or training center available for sampling.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#J">J.</span> If the trainer or other custodian of a selected horse refuses or declines to make the horse available for sampling and the managing owner has previously provided the Commission with a means for the Commission to give immediate notification to the managing owner in such situation, then the Commission shall attempt to notify the managing owner and the eligibility of the horse shall be preserved if the managing owner is able to make the horse available for immediate sampling. The Commission is not required to make repeated attempts to notify the managing owner.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#K">K.</span> The chain of custody record for the sample (including a split sample where appropriate) shall be maintained and made available to the trainer, owner, or their designee when a complaint results from an out-of-competition test.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#L">L.</span> The Commission may have out-of-competition samples tested to produce information that may enhance the ability of the Commission to enforce its medication and anti-doping rules.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#M">M.</span> An out-of-competition sample that is found to contain a prohibited substance may be adjudicated in the same manner as a post-race sample that is found to contain a prohibited substance.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#N">N.</span> Split sample rules and procedures for post-race testing shall apply to out-of competition testing.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#O">O.</span> The Commission may use any remaining sample for research and investigation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#P">P.</span> Willful failure to make a horse available for sampling or other willfully deceptive acts or interference in the sampling process shall constitute a violation of the Commission’s laws and regulations and may be subject to penalties available under the applicable laws and regulations.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/09.10.03.10#Q">Q.</span> A selected horse that is presumed eligible for out-of-competition testing shall be placed on the Steward’s list and will be ineligible to race in the jurisdiction for 180 days if the horse is not sampled due to the trainer’s, owner’s or their designee’s assertion that the horse is not engaged in activities related to competing in horse racing in the State. This restriction does not apply if the trainer, owner, or their designee voluntarily allows an immediate collection of the samples from the horse.</p>
                <hr class="section-separator" aria-hidden="true"/>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/09.10.02" aria-label="Chapter 02 Harness Racing">
                <div class="h__ui">Previous</div>
                <span>Chapter 02 Harness Racing</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/09.10.04" aria-label="Chapter 04 General">
                <div class="h__ui">Next</div>
                <span>Chapter 04 General</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">
<p>This version of the laws and codes on this website is licensed under the <a href="https://creativecommons.org/licenses/by-nc-sa/4.0/">CC BY-NC-SA 4.0</a> license with copyright held by the State of Maryland.</p><p>This version of the laws and codes on this website will be dedicated to the public domain under the <a href="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0</a> license 180 days after publication.</p>
<p>
      Please do not scrape. Instead, bulk download the CC BY-NC-SA-4.0 <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p><p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p></div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
